Thomas J. Kaley, MD - MSK Neuro-Oncologist & Early Drug Development Specialist

Neurology often feels like a maze of specialists, each corner leading to another sub-specialty. Thomas J. Kaley, MD cuts through that complexity with a rare combination of expertise—neuro-oncology and early drug development. The practice sits at 160 E 53rd St, New York, NY 10022, a stretch of Midtown where medical offices blend with the rhythm of city life without drawing too much attention to themselves. For patients navigating brain or spinal cord tumors, this kind of focused care can make all the difference, especially when treatment options extend beyond standard protocols.

This isn’t a general neurology clinic. Dr. Kaley’s work centers on tumors affecting the nervous system, including gliomas, meningiomas, and metastases, as well as the experimental therapies that might offer new hope. The field itself moves quickly, with clinical trials and emerging drugs reshaping what’s possible. To discuss whether a case might fit into that landscape, the number to call is (347) 971-3051. Midtown’s density means parking can be tricky, but the trade-off is access—subways, buses, and cabs all converge nearby, making it easier to reach than some quieter, more remote locations.

Neuro-oncology isn’t a specialty you stumble into by accident. It demands precision, patience, and a willingness to engage with uncertainty. For anyone in New York seeking that level of care, the office provides a starting point. Directions are straightforward: map here. Sometimes, the right specialist isn’t the closest one—just the one who understands the problem best.